Our study corroborated these findings; the TIM-3+ frequencies in CD34+, CD34+CD38−, and CD34+CD38+ cells were comparable between t(8;21) and inv(16) subtypes, with both subtypes showing significantly higher levels than non-CBF-AML patients. The gene discussed is HAVCR2; the disease is acute myeloid leukemia.